Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06942741 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)
A Phase 1 study, sponsored by Merck Sharp & Dohme.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT06942741 is a Phase 1 study that has completed, run by Merck Sharp & Dohme. The registered enrollment target is 52 participants.
The verdict
NCT06942741, a Phase 1 study, has completed, sponsored by Merck Sharp & Dohme.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study has 2 parts. Researchers want to learn what happens to calderasib in a healthy person's body over time in both parts. The goals of the study are: * In Part 1, to compare what happens to calderasib in a person's blood when it is taken as 2 different types of oral tablets * In Part 2, to learn what happens to calderasib in a person's blood when it is taken on an empty stomach or after a meal
Interventions
- DRUG Calderasib OCT
- DRUG Calderasib FCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2025-05-13 |
| Est. Completion | 2025-08-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06942741
The ClinicalTrials.gov registry entry for NCT06942741 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Calderasib OCT is the first listed.
NCT06942741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06942741 about?
NCT06942741 is a clinical study titled "A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)". This study has 2 parts. Researchers want to learn what happens to calderasib in a healthy person's body over time in both parts. The goals of the study are: * In Part 1, to compare what happens to calderasib in a person's blood when it is taken as 2 different types of oral tablets * In Part 2, to l...
What is the current status of trial NCT06942741?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2025-05-13. Estimated completion is 2025-08-04.
What interventions are being tested in trial NCT06942741?
The interventions under investigation include: Calderasib OCT (DRUG), Calderasib FCT (DRUG).
Who is sponsoring clinical trial NCT06942741?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.